Human epidermal growth factor receptor 2 (HER2) and triple negative breast cancer (TNBC) have a relatively poor prognosis among breast cancer, and EVs from patients of these subtypes had lower F/B ratios [24,25]. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.